PHARMA MAR, S.A. - stock earnings
PHM.MC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -6.8 million EUR | 40.5 million EUR |
| 2023Q3 | 1.5 million EUR | 37.5 million EUR |
| 2023Q2 | 5.0 million EUR | 46.2 million EUR |
| 2023Q1 | 1.4 million EUR | 34.0 million EUR |
| 2022Q4 | 1.4 million EUR | 54.9 million EUR |
| 2022Q3 | 13.0 million EUR | 40.0 million EUR |
| 2022Q2 | 12.9 million EUR | 48.2 million EUR |
| 2022Q1 | 22.0 million EUR | 53.2 million EUR |
| 2021Q4 | 38.2 million EUR | 85.9 million EUR |
| 2021Q3 | 11.5 million EUR | 45.3 million EUR |
| 2021Q2 | 19.0 million EUR | 47.4 million EUR |
| 2021Q1 | 24.2 million EUR | 51.3 million EUR |
| 2020Q4 | 6.2 million EUR | 47.8 million EUR |
| 2020Q3 | 17.3 million EUR | 53.0 million EUR |
| 2020Q2 | 43.2 million EUR | 69.7 million EUR |
| 2020Q1 | 70.6 million EUR | 99.5 million EUR |
| 2019Q4 | 15.6 million EUR | 23.3 million EUR |
| 2019Q3 | -5.7 million EUR | 21.1 million EUR |
| 2019Q2 | -10.8 million EUR | 22.0 million EUR |
| 2019Q1 | -10.5 million EUR | 19.4 million EUR |
| 2018Q4 | -10.6 million EUR | 28.8 million EUR |
| 2018Q3 | 2.0 million EUR | 26.4 million EUR |
| 2018Q2 | 4.4 million EUR | 62.4 million EUR |
| 2018Q1 | -1.3 million EUR | 44.6 million EUR |
| 2017Q4 | -12.3 million EUR | 38.9 million EUR |
| 2017Q3 | -7.0 million EUR | 43.5 million EUR |
| 2017Q2 | -5.0 million EUR | 51.5 million EUR |
| 2017Q1 | -2.5 million EUR | 45.5 million EUR |
| 2016Q4 | -7.5 million EUR | 41.3 million EUR |
| 2016Q3 | -3.4 million EUR | 47.5 million EUR |
| 2016Q2 | -6.0 million EUR | 50.0 million EUR |
| 2016Q1 | -7.1 million EUR | 42.2 million EUR |
| 2015Q4 | -1.1 million EUR | 66.0 million EUR |
| 2015Q3 | 4.4 million EUR | 42.5 million EUR |
| 2015Q2 | -3.2 million EUR | 49.4 million EUR |
| 2015Q1 | 6.5 million EUR | 35.0 million EUR |
| 2014Q4 | -4.4 million EUR | 31.8 million EUR |
| 2014Q3 | 770000 EUR | 38.7 million EUR |
| 2014Q2 | -147000 EUR | 44.0 million EUR |
| 2014Q1 | 16.9 million EUR | 34.2 million EUR |
| 2013Q4 | -2.8 million EUR | 31.2 million EUR |
| 2013Q3 | -309000 EUR | 37.9 million EUR |
| 2013Q2 | -1.4 million EUR | 40.5 million EUR |
| 2013Q1 | 15.8 million EUR | 30.8 million EUR |
| 2012Q4 | -4.7 million EUR | 65.5 million EUR |
| 2012Q3 | -3.4 million EUR | 36.8 million EUR |
| 2012Q2 | 15.5 million EUR | 41.4 million EUR |
| 2012Q1 | -5.8 million EUR | 31.3 million EUR |
| 2011Q4 | 7.8 million EUR | 71.2 million EUR |
| 2011Q3 | -6.7 million EUR | 39.4 million EUR |
| 2011Q2 | -1.6 million EUR | 45.9 million EUR |
| 2011Q1 | -4.7 million EUR | 35.4 million EUR |
| 2010Q4 | -6.8 million EUR | 33.5 million EUR |
| 2010Q3 | -2.4 million EUR | 41.3 million EUR |
| 2010Q2 | -1.2 million EUR | 45.8 million EUR |
| 2010Q1 | -2.0 million EUR | 32.9 million EUR |
| 2009Q4 | -13.1 million EUR | 28.2 million EUR |
| 2009Q3 | -8.2 million EUR | 35.0 million EUR |
| 2009Q2 | -3.0 million EUR | 38.1 million EUR |
| 2009Q1 | -3.9 million EUR | 22.1 million EUR |
| 2008Q4 | -18.8 million EUR | 22.5 million EUR |
| 2008Q3 | -12.5 million EUR | 28.6 million EUR |
| 2008Q2 | -1.4 million EUR | 32.8 million EUR |
| 2008Q1 | -11.0 million EUR | 21.4 million EUR |
PHM.MC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.1 million EUR | 158.2 million EUR |
| 2022 | 49.4 million EUR | 196.3 million EUR |
| 2021 | 92.9 million EUR | 229.8 million EUR |
| 2020 | 137.3 million EUR | 270.0 million EUR |
| 2019 | -9.2 million EUR | 85.8 million EUR |
| 2018 | -5.5 million EUR | 162.2 million EUR |
| 2017 | -26.7 million EUR | 179.3 million EUR |
| 2016 | -24.1 million EUR | 180.9 million EUR |
| 2015 | 6.6 million EUR | 192.8 million EUR |
| 2014 | 13.1 million EUR | 148.7 million EUR |
| 2013 | 11.3 million EUR | 140.5 million EUR |
| 2012 | 6.6 million EUR | 138.2 million EUR |
| 2011 | -1.4 million EUR | 152.5 million EUR |
| 2010 | -12.3 million EUR | 153.5 million EUR |
| 2009 | -28.1 million EUR | 123.4 million EUR |
| 2008 | -43.7 million EUR | 105.3 million EUR |
| 2007 | -50.7 million EUR | 85.5 million EUR |
| 2006 | -48.6 million EUR | 76.2 million EUR |
| 2005 | 42000 EUR | 471000 EUR |
| 2004 | 1.4 million EUR | 669000 EUR |
| 2003 | -26.2 million EUR | 80.3 million EUR |
| 2002 | -35.3 million EUR | 65.9 million EUR |
PHM.MC
Price: €28.82
52 week price:
Dividend Yield: 0.02%
5-year range yield:
Forward Dividend Yield: 1.83%
Payout Ratio: 67.50%
Payout Ratio Range:
Dividend Per Share: 0.53 EUR
Earnings Per Share: 0.06 EUR
P/E Ratio: 44.77
Exchange: MCE
Sector: Healthcare
Industry: Biotechnology
Volume: 42769
Market Capitalization: 474.5 million
Average Dividend Frequency: 1
Years Paying Dividends: 4